News from the AGA

Meet our 2018 AGA Research Scholar Award recipients


 

The six investigators awarded AGA’s flagship research grant are working on impressive research projects that address important unmet needs for GI patients.

In partnership with generous supporters, the AGA Research Foundation provided more than $2 million in research funding to 41 investigators in 2018. The AGA Research Scholar Award was given to 6 exceptional early-career investigators who represent the future of GI research. Read about their research projects below.

Sarah Andres, PhD

University of Pennsylvania, Philadelphia

Project title: The mRNA binding protein IMP1 regulates intestinal epithelial exosome biology during homeostasis and metastasis

Dr. Andres will use this award to delve more deeply into understanding how RNA binding proteins regulate exosomes within the intestinal and colonic epithelium and how this plays a part in health and disease. RNA binding proteins provide an exquisite layer of biological regulation to gene expression and downstream cellular processes, which is only beginning to be appreciated. Dr. Andres’s long-term hope is that her work will improve the diagnosis, treatment, and ultimately survival of patients with colon cancer.

Swathi Eluri, MD, MSCR

University of North Carolina at Chapel Hill

Project title: Improving Barrett’s esophagus screening practices in primary care

Dr. Eluri’s AGA-funded project will gather data to develop and test a multi-level screening intervention for Barrett’s esophagus to be implemented in primary care. The ultimate goal of her work is to improve esophageal adenocarcinoma detection. Given our highly effective endoscopic therapies for early neoplasia in Barrett’s esophagus, early detection has the potential to yield substantial benefits for patients.

Jill Hoffman, PhD

University of California, Los Angeles

AGA-Takeda Pharmaceuticals Research Scholar Award in IBD

Project title: Characterization of CRHR2-mediated enteric glial cell function during colitis

Dr. Hoffman will use her AGA-Takeda funding to define a role for corticotropin-releasing hormone (CRH) signaling in enteric glial cell function, and determine CRHR2-dependent crosstalk between enteric glial cells and the intestinal epithelium during inflammation. Through research aiming to understand the basic mechanisms of cell-to-cell signaling during intestinal inflammation, Dr. Hoffman hopes to determine how to harness these pathways to limit inflammation and promote repair in patients with IBD.

Elizabeth Jensen, MPH, PhD

Wake Forest University, Winston-Salem, NC

Project title: Early life factors, gene-environment interaction, and eosinophilic esophagitis (EoE)

With this funding, Dr. Jensen will conduct the largest study to date on early life factors and EoE, using data that have been collected prospectively through population-based registries in Denmark. Ultimately, Dr. Jensen hopes her research will lead to advancements in our understanding of etiologic factors for development of immune-mediated GI diseases, such as EoE, and will lead to the identification of modifiable factors for disease prevention.

Sumera Rizvi, MD

Mayo Clinic, Rochester, MN

Project title: Necrosis enhances tumor immunogenicity and augments cholangiocarcinoma tumor suppression in combination with PD-L1 blockade

Dr. Rizvi’s research is focused on elucidating immunogenic cell death mechanisms and exploring novel, immune-mediated therapeutic approaches in cholangiocarcinoma. This work has the potential to open novel therapeutic avenues for treatment of cholangiocarcinoma, which will ultimately improve the outcomes of patients with this devastating malignancy.

Next Article: